ORIGINATORS
Originators are developed after many years of laboratory and clinical research and they are subject to strict regulations that ensure their quality, safety and effectiveness.
READ MORE | TRADE NAME | ACTIVE INGREDIENT | THERAPEUTIC CLASSIFICATION |
|---|
| Nipent | Pentostatin | Antineoplastic drug |
| Teysuno | Tegafur, Gimeracil, Oteracil | Antineoplastic drug |
The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).
GENERICS
Providing safe generics gives patients who would not be able to buy the originator, access to effective treatment, while it saves a great amount of money for the national health system and releases the resources for more expensive treatments.
READ MORE | TRADE NAME | ACTIVE INGREDIENT | THERAPEUTIC CLASSIFICATION |
|---|
| Londer | Anastrozole | Endocrine treatment |
| Oxaliplatin / Hospira | Oxaliplatin | Antineoplastic drug |
| Irinotecan Hydrocloride Trihydrate / Hospira | Irinotecan Hydrochloride Trihydrate | Antineoplastic drug |
| Carboplatin / Hospira | Carboplatin | Antineoplastic drug |
| Gemcipen | Gemcitabine Hydrochloride | Antineoplastic drug |
| Letropen | Letrozole | Endocrine treatment |
| Paclitaxel / Hospira | Paclitaxel | Antineoplastic drug |
| Topotecan / Hospira | Topotecan | Antineoplastic drug |
| Docetaxel / Hospira | Docetaxel | Antineoplastic drug |
| Cisplatin / Hospira | Cisplatin | Antineoplastic drug |
| Ridoca | Temozolomide | Antineoplastic drug |
| Zoledronic Acid Hospira | Zoledronic Acid Monohydrate | Drug for bone disease treatment |
| Levetiracetam Hospira | Levetiracetam | Antiepileptic |
| Imatinib / Aenorasis | Imatinib | Oncology, Haematology |
| Imipenem Cilastatin / Hospira | Imipenem Cilastatin | |
| Vincristine / Hospira | Vincristine | |
The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).
BIOSIMILARS
Introducing Biosimilars in the international pharmaceutical market improves patients' access to effective treatments, it allows the medical community to provide cost-effective choices and it reduces significantly the total cost of treatment and of the total pharmaceutical expenditure.
READ MORE | TRADE NAME | ACTIVE INGREDIENT | THERAPEUTIC CLASSIFICATION |
|---|
| Retacrit | Epoetin Zeta | Drug for Aneamia |
| Nivestim | Filgrastim | Immunostimulative agent |
| Inflectra | Infliximab | Immunosuppresant agent |
The aforementioned drugs are prescribed and should be used only following medical guidance and always according to the approved by the National Organization for Medicines guidelines (EOF).
RADIOPHARMACEUTICALS
Nuclear Medicine studies the structure and the metabolism of human tissues, with the use of radiopharmaceuticals and radioisotopes. It is an important, rapidly changing sector, which develops products vital to human health.
READ MORE DIAGNOSIS
— Diagnostic Radiopharmaceuticals and Radioisotopes
SPECT (Single Photon Emission Computed Tomography) Radiopharmaceuticals and radioisotopes. They are administered intravenously and selectively absorbed by the organs and tissues, providing useful information for the assessment of organ function and for the diagnosis of possible failures.
CLASSIFICATION (PER INDICATION)
Adrenal glands/KidneysNORCHOL-131
PENTACIS
RENOCIS
STAMICIS
THALLIUM (201TL) CHLORIDE/ΕΝΟΡΑΣΙΣ
CLASSIFICATION (PER PRODUCT GROUP)
Radioisotopes & RadiopharmaceuticalsGA-67-MM-1
NORCHOL-131
THALLIUM (201TL) CHLORIDE/ΕΝΟΡΑΣΙΣ
TEKCIS
PENTACIS
PULMOCIS
RENOCIS
SCINTIMUN
STAMICIS
TECEOS
PHYTACIS
— Radio-immuno-assays (RIA)
In vitro radioisotopes are used to quantify the level of various substances (tumor markers, proteins) in biological fluids (blood, serum, plasma, saliva, urine).
CLASSIFICATION (PER INDICATION)
Auto-immunityTR-AB-CT (Anti-TSH Receptor Autoantibodies
21-OH-AB (21-Hydroxylase Autoantibodies)
GAD-AB (Anti-GAD Autoantibodies)
IA2-AB (Anti-IA2 Autoantibodies)
AAI (Insulin Autoantibodies)
TPO-AB-CT (TPO Autoantibodies)
MSK/TR (Musk)
TG-AB I STEP (Thyroglobulin Autoantibodies)
VGKC/25 (VGKC Autoantibodies)
ELSA-ACTH (Adreno-corticotropic hormone)
R-GM-100 (Androstenedione)
21-OH-AB (21-Hydroxylase Autoantibodies)
CORT-CT2 (Cortisol)
ESTR-CTRIA (Estradiol)
ESTR-US-CT (Estradiol Ultrasensitive)
OCPM03-HCG (human Chorionic Gonadotropine)
ELSA-FβHCG (Free β hCG – β chains)
OHP-CT (17 OH-Progesterone)
17-OHP-NN (17 OH-Progesterone Neonatal)
TESTO-CT2 (Testosterone)
IA2-AB (Anti-IA2 Autoantibodies)
AAI (Insulin Autoantibodies)
GAD-AB (Anti-GAD Autoantibodies)
IRMA-C-PEP (C-Peptide)
BI-INS-IRMA (Insulin IRMA)
INSULIN-CT (Insulin)
ALDO-RIACT (Aldosterone)
REN-CT2 (Angiotensin I)
RENINE (Renin)
TG-AB I STEP (Thyroglobulin Autoantibodies)
TR-AB-CT (Anti-TSH Receptor Autoantibodies
TPO-AB-CT (TPO Autoantibodies)
IRMA-HCT (Calcitonin)
OCPE07-T3 (Tri-iodo-thyronine 100 tubes)
OCPE57-T3 (Tri-iodo-thyronine 500 tubes)
OCFH07-FT3 (Free tri-iodo-thyronine 100 tubes)
OCFH57-FT3 (Free tri-iodo-thyronine 500 tubes)
OCPG07-T4 (Thyroxine 100 tubes)
OCPG57-T4 (Thyroxine 500 tubes)
OCFD03-FT4 (Free thyroxine 100 tubes)
OCFD57-FT4 (Free thyroxine 500 tubes)
OCRU03-TBG (TBG)
THYRO (Thyroglobulin)
OCPL07-TSH (Thyroid stimulating hormone, 100 tubes)
OCPL57-TSH (Thyroid stimulating hormone, 500 tubes)
ELSA-TSH-NN (TSH Neonatal)
ELSA2-AFP (αlpha fetoprotein)
ELSA-FβHCG (Free β hCG – β chains)
IRMA-HCT (Calcitonin)
ELSA-CA 125II (CA 125)
ELSA-CA 15-3 (CA 15-3)
ELSA-CA 19-9 (CA 19-9)
OCFM07-CA50 (CA 50)
ELSA-CA 72-4 (CA 72-4)
CEA-RIACT (CEA)
CGA-RIACT (Chromogranin A)
ELSA-CYFRA (Cyfra 21-1)
ELSA-NSE (NSE)
PSA-RIACT (PSA total)
FPSA-RIACT (PSA free)
THYRO (Thyroglobulin)
HGH-RIACT (Human Growth Hormone)
IGF1 (IGF1)
OSTEO-RIACT (Osteocalcin)
ELSA-PTH (PTH)
TREATMENT
— Therapeutic radiopharmaceuticals
Therapeutic radiopharmaceuticals which have the advantage of concentrating on the pathogenesis and administering energy, without damaging healthy tissues and without burdening the organism with toxins.
CLASSIFICATION (PER INDICATION)
JointsERMM-1 (Erbium 169 citrate)
ΥΜΜ-1 (Υttrium 90 citrate)
RE-186-MM-1 (Rhenium 186 sulphide)
QUADRAMET (Samarium 153 Lexidronam pentasodium)
